SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is generating buzz among traders who are attracted to its active developer engagement and the community's push to build organic momentum, despite the project's early stage and lack of an official chart. Investors are actively discussing the potential for a significant breakout, emphasizing the need for sustained volume and broader social media promotion to move the token toward mainstream visibility.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN CRYPTO) is currently trending as members debate its viability, with many in the community labeling it a pump-and-dump scheme or comparing it to the Mullen Automotive stock decline. While some users attempt to rally interest through community-led narratives and crypto-market speculation, others are actively warning investors to exit to avoid potential financial losses.

iShares Inc. - iShares MSCI Mexico ETF

iShares MSCI Mexico ETF

Investors are actively debating the long-term viability of Mexico as a manufacturing hub, with some noting its strategic importance in nearshoring supply chains while others warn of socio-economic decay and political risks. The community is focused on the impact of trade tariffs and US-Mexico relations on the performance of $EWW.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The XRP community remains deeply divided, with some investors accumulating tokens in anticipation of regulatory clarity and institutional adoption, while others express frustration over long-term price stagnation and perceived lack of progress. Debates are currently fueled by speculation surrounding the Clarity Act and the expansion of Ripple's payment infrastructure, leading to a polarized environment between optimistic long-term holders and disillusioned skeptics.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors monitor its development as a rare earth metals processor amid increasing urgency for U.S.-aligned supply chains. The community is actively debating the stock's long-term potential in the defense sector, with heavy discussions focused on the company's advisory board appointments, defense-related contracts, and the risks versus rewards associated with future production timelines.

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.

KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals is trending following an Endpoints News report alleging that FDA Commissioner Marty Makary attempted to force a rejection of the company's hereditary angioedema (HAE) drug application, an effort that was reportedly blocked by internal FDA scientists. Investors are actively discussing the stock's resilience, as the company maintains its path toward potential approval for the first oral on-demand treatment for HAE while bulls view the resulting price volatility as a favorable opportunity to increase positions.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently a focal point for investors due to clinical progress with its ITK inhibitor, soquelitinib, which has generated buzz for its potential to deliver durable, disease-modifying outcomes in atopic dermatitis and oncology. Community sentiment remains highly polarized, with intense debate between bulls anticipating a strategic buyout or short squeeze and skeptics emphasizing the inherent risks of a clinical-stage biotech and the potential for share dilution.

Invesco Exchange-Traded Fund Trust II - Invesco Solar ETF

Invesco Solar ETF

Invesco Solar ETF is navigating heightened market volatility as investors weigh the impact of shifting political landscapes and policy rhetoric on long-term renewable energy demand. The community is actively debating the sector's resilience, with many pointing to the structural necessity of solar to support the power-intensive growth of AI and data center infrastructure despite short-term regulatory headwinds.

ETF Series Solutions - ESS U.S.Global Jets ETF

US Global Jets ETF

Airline stocks are facing renewed volatility as the sector grapples with potential operational disruptions, fuel cost pressures, and broader economic uncertainty. The community is actively debating the sustainability of travel demand and debating whether the recent price action offers a contrarian value opportunity or a warning of deeper industry headwinds.

Investment Managers Series Trust II - Tradr 1.5X Short NVDA Daily ETF

Tradr 1.5X Short NVDA Daily ETF

The $NVDS ETF is seeing intense activity as traders debate whether Nvidias rally is sustainable or if a major pullback is imminent. The community is heavily focused on using this inverse instrument as a tactical hedge or aggressive short, with active discussions weighing technical support levels and the risks of betting against such a volatile market leader.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nifty faces key resistance at 25,200 amid geopolitical tensions

Following Friday’s rally, Nifty now faces a crucial test near 25,200. Analysts say a sustained move above this level could pave the way for a further rise toward 25,700–25,900, but also caution that geopolitical uncertainties may continue to inject volatility into the markets. On the downside, support at 24,500 remains crucial with stock-specific action in banks, midcaps, and select names like M&M, BEL, and CAMS offering trading opportunities.RUCHIT JAIN VICE PRESIDENT, MOTILAL OSWAL FINANCIAL SERVICESWhere is Nifty headed this week? Geopolitical tensions have led to a consolidation phase in Indian markets over the past month. However, this appears to be a time-wise corrective phase within an uptrend, with Nifty holding above its support zone of 24,500– 24,450—a crucial near-term level. The immediate hurdle for the index lies in the 25,200–25,250 range. A breakout above this could propel the index towards 25,500–25,700. On the downside, 24,800 is the immediate support, followed by positional support at 24,450.

Indian equity benchmarks ended higher on Thursday, driven by global trade relief after a U.S. federal court blocked President Donald Trump’s sweeping “Liberation Day” tariffs, calling them an illegal overreach of executive power.The ruling, which has been appealed by the Trump administration, temporarily eases trade tensions.&nbsp;The Sensex ended 320 points higher to close at 81,633, while the Nifty 50 gained 81 points to finish at 24,833 in a choppy monthly expiry session.&nbsp;The broader markets outperformed, the Nifty Midcap index and the Smallcap index gained 0.6%.&nbsp;Meanwhile, retail investor sentiment surrounding the Nifty 50 has turned ‘extremely bullish’.<figure class="image"><img style="aspect-ratio:806/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_29_161707_png_47f24279d1.webp" alt="Screenshot 2025-05-29 161707.png" width="806" height="104"><figcaption>Nifty sentiment and message volume on May 29 as of 4:15 pm IST. | source: Stocktwits</figcaption></figure>On the sectoral front, metals, IT, and pharma stocks witnessed a relief rally, driven by easing trade concerns after the U.S. court ruling.&nbsp;MMTC shares surged 20%, hitting an upper circuit, despite weak March-quarter earnings.&nbsp;Positive management commentary post Q4 earnings drove Samvardhana Motherson (+3%) and Cummins (+7%) higher.&nbsp;Other earnings gainers include Deepak Nitrite, Mishra Dhatu Nigam, and Deepak Fertilisers, which surged 5% each.&nbsp;On the other hand, Bharat Rasayan ended 9% lower due to disappointing earnings performance.Waaree Energies ended 8% higher after its international subsidiary won an order worth $176 million.Castrol India surged 6% after reports indicated that Reliance Industries and Aramco are in the fray to acquire BP’s lubricant business, which operates under the Castrol brand.Olectra Greentech extended its losses for the third consecutive session, ending 4% lower.Vedanta gained 2% after the National Company Law Appellate Tribunal (NCLAT) granted an interim stay on an earlier order by the National Company Law Tribunal (NCLT) that rejected the mining major's demerger scheme.IndusInd Bank ended over 2% higher despite the market regulator SEBI barring five top executives, including the ex-CEO, in an insider trading case.&nbsp;&nbsp;Globally, European markets traded higher, and Dow Futures pointed to a strong opening for Wall Street.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Indian Markets End Higher, Nifty Tops 24,800: Metals, IT Rally As US Court Halts Trump Tariffs

Retail sentiment on the Nifty 50 turned ‘extremely bullish’ as Indian equities ended higher on relief from U.S. trade risks. 

Equity

Retail sentiment on the Nifty 50 turned ‘extremely bullish’ as Indian equities ended higher on relief from U.S. trade risks. 


Indian equity benchmarks opened firm on Thursday, tracking strong Asian cues after a U.S. court blocked President Donald Trump’s tariff orders.&nbsp;This pushed the Nifty 50 past 24,800 ahead of the monthly F&amp;O expiry session.&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nifty-levels-to-watch-may29/ch0Aa4HRbsC">Analysts</a> highlight that the 24,500–25,000 range remains the key battleground.&nbsp;At 9:40 a.m. IST, the Nifty 50 had risen 59 points to 24,811, while the Sensex was up 226 points to 81,538.&nbsp;Broader markets outperform with the Nifty Midcap index gaining 0.3% and the Nifty Smallcap index rising 0.5%The retail sentiment also turned sharply positive on Stocktwits and flipped to ‘extremely bullish’.&nbsp;<figure class="image"><img style="aspect-ratio:792/96;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_29_095930_png_0674af3e6e.webp" alt="Screenshot 2025-05-29 095930.png" width="792" height="96"><figcaption>Nifty sentiment and message volume on May 29 as of 10:00 am IST. | source: Stocktwits</figcaption></figure>Sectorally, technology was the leading gainer. Metal and pharma stocks witnessed a relief rally after a U.S. federal court found that Trump had exceeded his authority when implementing "reciprocal" tariffs on over 180 countries and territories in April and deemed the move illegal.On the flip side, FMCG stocks remained under pressure, with some weakness in select financials, oil and gas, and real estate stocks.&nbsp;Many midcap stocks are reacting to March quarter (Q4 FY25) earnings. Avanti Feeds surged 5%, and Mishra Dhatu Nigam rose 4% on strong earnings. Deepak Nitrite, SAIL, and IRCTC also saw gains between 2% and 1%.&nbsp;Meanwhile, Bharat Rasayan fell 7% and Balaji Amines slipped 3%, dragged by weak Q4 earnings.&nbsp;Nuvama rose 3%, driven by a good show in the March quarter earnings. Citi has reiterated a ‘Buy’ call with a target of ₹8,850, indicating a 28% upside.&nbsp;Fluorochem slipped 1% after UBS maintained a ‘Sell’ rating with a target of ₹3,000, implying a 22% downside.&nbsp;IndusInd Bank traded 0.6% higher despite the market regulator’s ban on five senior executives, including the ex-CEO, in an insider trading case.&nbsp;Looking ahead, investors will monitor&nbsp;Bajaj Auto, IPCA Laboratories, Alkem Labs, EIL, Lemon Tree Hotels, Samvardhana Motherson, NBCC, and Suzlon&nbsp;among others, as they report quarterly numbers later in the day.&nbsp;From a technical standpoint, SEBI-registered analysts on Stocktwits shared the trade setup.&nbsp;Prabhat Mittal pegged immediate support for the Nifty at 24,700 and resistance at 24,900, while he placed Bank Nifty support at 55,200 and resistance at 55,800.<stembedurl>https://stocktwits.com/prabhatmittal1/message/616143474</stembedurl>For intraday trading, A&amp;Y Market Research sees Nifty resistance levels at 24,746 - 24,811, while support lies between 24,455 - 24,507.&nbsp;In the case of Bank Nifty, resistance is pegged at 55,443 - 55,557, with support between 54,334 - 54,470.<stembedurl>https://stocktwits.com/aymr_sebi_ra/message/616145745</stembedurl>Asian markets traded higher and U.S. futures surged, driven by Nvidia’s strong earnings and easing trade concerns after the U.S. court ruling.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Nifty Opens Above 24,800 Ahead Of F&O Expiry: IT, Metals Rally On US Court’s Tariff Ruling

 Indian equity markets opened higher following a U.S. court’s block on Trump’s tariff orders and positive Asian cues. 

Bharat Rasayan Ltd. engages in the business of agrochemicals. It manufactures technical grade pesticides, formulations, and intermediates. The company was founded by Sat Narain Gupta, Mahabir Prasad Gupta, and Rajender Prasad Gupta on May 15, 1989 and is headquartered in New Delhi, India.

BHARATRAS.NSE
Bharat Rasayan Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest BHARATRAS.NSE News

BHARATRAS.NSEBharat Rasayan Ltd.